LEO Pharma A/S, a global leader in medical dermatology, today announced the presentation of new post-hoc analyses of 12‑month real‑world data from the TRACE study of tralokinumab, at the 2026 American ...
Nasdaq NASX will roll out a set of rules including steps to speed up the entry of newly listed large-cap companies to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results